-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Compensated liver cirrhosis is characterized by portal hypertension and liver failure.
Compensated liver cirrhosis is characterized by portal hypertension and liver failure.
Researchers collected randomized controlled trials on long-term use of albumin in patients with liver cirrhosis and liver ascites in various databases.
A total of five randomized controlled trials that met the selection criteria were included in the meta-analysis, involving a total of 716 patients.
Figure: The relationship between long-term use of albumin and the prognosis of liver cirrhosis
The author finally said: Long-term use of albumin in patients with liver cirrhosis and liver ascites can reduce the need for recurrence of ascites and the need for puncture, but there is no evidence that long-term use of albumin has an effect on the mortality of liver cirrhosis.
Long-term use of albumin in patients with liver cirrhosis and liver ascites can reduce ascites recurrence and the need for puncture, but there is no evidence that long-term use of albumin has an effect on the mortality of liver cirrhosis.
Original source:
Bianca Boff Sandi.
wiley.
com/doi/10.
1111/jgh.
15253" target="_blank" rel="noopener">Long‐term albumin administration in patients with cirrhosis and ascites: A meta‐analysis of randomized controlled trials.
Leave a message here